PAP: a pioneer in patient care that fills the gaps in national health insurance
AI-translated from the Chinese original · editorially reviewed
In today's healthcare systems, financial factors often become the deciding consideration in a cancer patient's treatment journey. The limits of national health insurance programs and personal financial constraints frequently restrict patients in their pursuit of the best treatment options. In the face of these challenges, pharmaceutical-funded Patient Assistance Programs (PAPs) have become a vital tool for overcoming financial barriers — particularly in filling the gaps left by national health insurance — opening the door to treatment for patients.
As PATIENTSFORCE's PAP consulting specialists, our mission is to help patients access new drug therapies and complete their full course of treatment through innovative solutions. The value of a PAP goes beyond financial aid: it is a comprehensive patient care strategy, a third-party healthcare benefit program that covers what national health insurance cannot.
The core value of all-around support
Our goal goes beyond any single form of aid: we ensure every patient receives attentive support throughout the treatment journey, unconstrained by financial considerations.
・Financial support: For patients whose national insurance coverage falls short of the high cost of cancer treatment, PAP provides urgently needed financial support, helping them manage the essential expenses of treatment with greater ease.
・Early support: While waiting for health insurance reimbursement to take effect, patients often have to shoulder treatment costs themselves. Through its "early bird" programs, PAP provides short-term financial support so patients can begin treatment promptly, without delays caused by financial concerns.
・Continued support: For patients who still need ongoing treatment after reaching the limits of health insurance coverage, PAP offers a reliable option to continue therapy. By creating more affordable payment arrangements, patients can more easily stay on course with treatment, without worrying that financial pressure will compromise their outcomes.
PAP effectiveness confirmed by empirical research in the US
Empirical research in the United States shows that PAPs have a clear positive impact on treatment duration and survival rates for patients paying for drugs out of pocket. The research underscores that by providing financial support, PAPs can significantly ease patients' financial pressure, increasing the likelihood that they complete their full treatment plan. This not only improves treatment outcomes but also brings meaningful gains in patients' quality of life.
PATIENTSFORCE: breaking down barriers as a key enabler on the road to treatment
As technology evolves, so does PatientsForce. As a professional consultancy, PATIENTSFORCE plays an indispensable role in the modern healthcare system, serving as an effective bridge between patients, healthcare providers and drug manufacturers. Beyond financial assistance, we offer diverse forms of support — including education, counseling and resource sharing — dedicated to breaking down the barriers patients face. We firmly believe that by working together, we can shape a more humane, barrier-free treatment environment on the stage of modern healthcare and safeguard the future health of every patient.
Claire Wang, Patient Relations Manager, Development and Project Business Division, Media-WIND Health Strategies, PatientsForce